Adenoid basal cell carcinoma: An underrecognized cervical malignancy
Cervical adenoid basal cell carcinoma is a rare malignancy that requires careful diagnostic attention due to its histologic similarities to more aggressive malignancies and the risk of misclassification. Advances in diagnostic criteria including immunohistochemistry (IHC) classification are key to distinguishing this unique pathological entity. Definitive treatment depends on accurate diagnosis. Optimal treatment involves surgical management with hysterectomy and lymph node assessment. Excisional biopsy with thorough pathologic evaluation for invasive carcinoma can be considered in patients who desire future fertility.
Authors
- Lisa Dos Santos (ORCID: https://orcid.org/0000-0002-8548-9858)
- Andrew Menzin
- Arielle Katcher
- Marina Frimer (ORCID: https://orcid.org/0000-0003-4968-1495)
- Juliana Schilsky
- Jill Whyte
- Tahyna Hernandez
- Alisha Daroch
Institutions
- Christiana Care Health System (US)
- Northwell Health (US)
- Feinstein Institute for Medical Research (US)
- Hofstra University (US)
- CUNY School of Law (US)
- Long Island Jewish Medical Center (US)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2024-12-22
- DOI
- https://doi.org/10.1016/j.gore.2024.101667
- Primary Topic
- Salivary Gland Tumors Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00